SEARCH

SEARCH BY CITATION

REFERENCES

  • Abdelrahim M, Smith R III, Safe S. 2003. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 63: 13731381.
  • Alvarez OA, Carmichael DF, DeClerck YA. 1990. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82: 589595.
  • Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. 2005. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: Implications for the epithelial-mesenchymal transition. J Cell Biol 168: 2933.
  • Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110: 5567.
  • Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, Greene WC. 1992. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89: 18751879.
  • Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, Baulida J, Franci C, Dedhar S, Larue L, Garcia de Herreros A. 2004. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 73457354.
  • Barrallo-Gimeno A, Nieto MA. 2005. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 132: 31513161.
  • Basseres DS, Baldwin AS. 2006. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 68176830.
  • Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 8489.
  • Belguise K, Sonenshein GE. 2007. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. J Clin Invest 117: 40094021.
  • Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. 2007. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, Slug and an invasive phenotype. Cancer Res 67: 1174211750.
  • Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, Mulvey LA, Shen RR, Ambrogio L, Hirozane-Kishikawa T, Hill DE, Vidal M, Meyerson M, Grenier JK, Hinkle G, Root DE, Roberts TM, Lander ES, Polyak K, Hahn WC. 2007. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129: 10651079.
  • Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 116: 499511.
  • Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23: 42024210.
  • Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U. 1993. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72: 729739.
  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 7683.
  • Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. 2001. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 21: 81848188.
  • Castanon I, Baylies MK. 2002. A Twist in fate: Evolutionary comparison of Twist structure and function. Gene 287: 1122.
  • Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S, Dougall WC. 2004. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. J Biol Chem 279: 5484154848.
  • Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. 2007. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 19791987.
  • Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. 2007. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711724.
  • Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS, Jr. 2000. Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19: 11231131.
  • Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79: 679694.
  • Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. 2001. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 12671278.
  • Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, Li H, Polosukhin VV, Blackwell TS, Yull FE. 2007. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J Biol Chem 282: 1002810035.
  • Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR. 1993a. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 11261131.
  • Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F. 1993b. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 53655369.
  • Eckes B, Dogic D, Colucci-Guyon E, Wang N, Maniotis A, Ingber D, Merckling A, Langa F, Aumailley M, Delouvee A, Koteliansky V, Babinet C, Krieg T. 1998. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 111(Pt 13): 18971907.
  • Eckes B, Colucci-Guyon E, Smola H, Nodder S, Babinet C, Krieg T, Martin P. 2000. Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 113(Pt 13): 24552462.
  • Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. 2005. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res 65: 1137511383.
  • Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R. 2005. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 23752385.
  • Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, Gonzalez FJ. 2000. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 57: 10561063.
  • Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, Reich R, Davidson B. 2005. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 16311643.
  • Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A, Mackay AR. 1999. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ 10: 353367.
  • Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA. 1987. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res 47: 15231528.
  • Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): S81S96.
  • Gilmore TD. 2003. The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241265.
  • Gilmore TD, Herscovitch M. 2006. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25: 68876899.
  • Gilmore T, Gapuzan ME, Kalaitzidis D, Starczynowski D. 2002. Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer. Cancer Lett 181: 19.
  • Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG, Baulida J. 2002. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277: 3920939216.
  • Guy CT, Cardiff RD, Muller WJ. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954961.
  • Hajra KM, Chen DY, Fearon ER. 2002. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62: 16131618.
  • Han YP, Tuan TL, Wu H, Hughes M, Garner WL. 2001. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114: 131139.
  • Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. 1996. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 15: 507525.
  • Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ. 1997. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14: 19951998.
  • Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, Yoshikawa K, Hannigan GE, Halaban R. 2004. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 52705282.
  • Hoffmann A, Leung TH, Baltimore D. 2003. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22: 55305539.
  • Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. 2007. Epithelial to mesenchymal transition: Expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 47694776.
  • Hua J, Muschel RJ. 1996. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56: 52795284.
  • Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. 2004. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569581.
  • Ikenouchi J, Matsuda M, Furuse M, Tsukita S. 2003. Regulation of tight junctions during the epithelium-mesenchyme transition: Direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116: 19591967.
  • Ikuta T, Kawajiri K. 2006. Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp Cell Res 312: 35853594.
  • Ip YT, Park RE, Kosman D, Yazdanbakhsh K, Levine M. 1992. dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev 6: 15181530.
  • Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N. 2003. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22: 71557169.
  • Jiang J, Kosman D, Ip YT, Levine M. 1991. The dorsal morphogen gradient regulates the mesoderm determinant twist in early Drosophila embryos. Genes Dev 5: 18811891.
  • Jiang HY, Petrovas C, Sonenshein GE. 2002. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: Differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J Virol 76: 57375747.
  • Jones JL, Walker RA. 1997. Control of matrix metalloproteinase activity in cancer. J Pathol 183: 377379.
  • Jones JL, Glynn P, Walker RA. 1999. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189: 161168.
  • Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A. 2005. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 118: 33713385.
  • Kajita M, McClinic KN, Wade PA. 2004. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 24: 75597566.
  • Kalaitzidis D, Gilmore TD. 2005. Transcription factor cross-talk: The estrogen receptor and NF-kappaB. Trends Endocrinol Metab 16: 4652.
  • Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM. 1998. Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb. Nature 392: 611614.
  • Kang Y, Massague J. 2004. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118: 277279.
  • Kim HJ, Litzenburger BC, Cui X, Delgado DA, Grabiner BC, Lin X, Lewis MT, Gottardis MM, Wong TW, Attar RM, Carboni JM, Lee AV. 2007. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 27: 31653175.
  • Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest PJ, Brandt B, Boecker W, Buerger H. 2005. The origin of vimentin expression in invasive breast cancer: Epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206: 451457.
  • Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ. 2000. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157: 17771783.
  • Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X. 2005. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65: 51535162.
  • La Rosa FA, Pierce JW, Sonenshein GE. 1994. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol Cell Biol 14: 10391044.
  • Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 181: 11691177.
  • Lilienbaum A, Paulin D. 1993. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem 268: 21802188.
  • Lilienbaum A, Duc Dodon M, Alexandre C, Gazzolo L, Paulin D. 1990. Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J Virol 64: 256263.
  • Ma Q, Whitlock J. 1996. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol 16: 21442150.
  • Martin TA, Goyal A, Watkins G, Jiang WG. 2005. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12: 488496.
  • Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S. 2006. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J 394: 449457.
  • McDonnell PC, Kumar S, Rabson AB, Gelinas C. 1992. Transcriptional activity of rel family proteins. Oncogene 7: 163170.
  • Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. 2007. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem 282: 1747517485.
  • Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C. 2005. Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: Potential therapeutic approaches for prostate cancer. Mol Carcinog 44: 110.
  • Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K. 2004. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90: 12651273.
  • Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Alvarez-Barrientos A, Catalina-Fernandez I, Hernandez-Nieto E, Saenz-Santamaria J, Martinez N, Rojas JM, Sanchez-Garcia I, Fernandez-Salguero PM. 2005. Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. J Biol Chem 280: 2873128741.
  • Nakajima M, Welch DR, Belloni PN, Nicolson GL. 1987. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 48694876.
  • Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr. 1997. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 36293639.
  • Nieto MA. 2002. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155166.
  • Nieto MA, Sargent MG, Wilkinson DG, Cooke J. 1994. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835839.
  • Ohkubo T, Ozawa M. 2004. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117: 16751685.
  • Pan DJ, Huang JD, Courey AJ. 1991. Functional analysis of the Drosophila twist promoter reveals a dorsal-binding ventral activator region. Genes Dev 5: 18921901.
  • Patel RD, Kim DJ, Peters JM, Perdew GH. 2006. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci 89: 7582.
  • Peinado H, Ballestar E, Esteller M, Cano A. 2004a. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 24: 306319.
  • Peinado H, Marin F, Cubillo E, Stark HJ, Fusenig N, Nieto MA, Cano A. 2004b. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci 117: 28272839.
  • Peinado H, Portillo F, Cano A. 2004c. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365375.
  • Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G. 2007. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27: 39203935.
  • Philip S, Bulbule A, Kundu GC. 2001. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 276: 4492644935.
  • Rayet B, Gelinas C. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 69386947.
  • Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A, Cippitelli M. 2000. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer 86: 188196.
  • Romano LA, Runyan RB. 1999. Slug is a mediator of epithelial-mesenchymal cell transformation in the developing chicken heart. Dev Biol 212: 243254.
  • Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. 2001. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res 61: 38103818.
  • Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23: 57385754.
  • Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF. 2002. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161: 18811891.
  • Safe S, Krishnan V. 1995. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch Toxicol Suppl 17: 99115.
  • Savagner P, Yamada KM, Thiery JP. 1997. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137: 14031419.
  • Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 14951499.
  • Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Lin SB, Liou GY, Lee ML, Chen JJ, Hong TM, Yang SC, Su JL, Lee YC, Yang PC. 2005. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res 11: 80708078.
  • Shin SR, Sanchez-Velar N, Sherr DH, Sonenshein GE. 2006. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. Cancer Res 66: 25702575.
  • Shioiri M, Shida T, Koda K, Oda K, Seike K, Nishimura M, Takano S, Miyazaki M. 2006. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 94: 18161822.
  • Sosic D, Olson EN. 2003. A new twist on twist—Modulation of the NF-kappa B pathway. Cell Cycle 2: 7678.
  • Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN. 2003. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169180.
  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE. 1997. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 29522960.
  • Spink BC, Hussain MM, Katz BH, Eisele L, Spink DC. 2003. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem Pharmacol 66: 23132321.
  • Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira S. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science 284: 313316.
  • Thisse C, Perrin-Schmitt F, Stoetzel C, Thisse B. 1991. Sequence-specific transactivation of the Drosophila twist gene by the dorsal gene product. Cell 65: 11911201.
  • Tohkin M, Fukuhara M, Elizondo G, Tomita S, Gonzalez FJ. 2000. Aryl hydrocarbon receptor is required for p300-mediated induction of DNA synthesis by adenovirus E1A. Mol Pharmacol 58: 845851.
  • Tripathi MK, Misra S, Chaudhuri G. 2005. Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells. Biochem Biophys Res Commun 329: 508515.
  • Van de Putte T, Maruhashi M, Francis A, Nelles L, Kondoh H, Huylebroeck D, Higashi Y. 2003. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet 72: 465470.
  • Van Waes C. 2007. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 10761082.
  • Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G. 2005. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions. Nucleic Acids Res 33: 65666578.
  • Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, Junquera S, Merino AM, Garcia-Muniz JL. 2007. Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96: 903911.
  • Vu TH, Werb Z. 2000. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 14: 21232133.
  • Wang SM, Coljee VW, Pignolo RJ, Rotenberg MO, Cristofalo VJ, Sierra F. 1997. Cloning of the human twist gene: Its expression is retained in adult mesodermally-derived tissues. Gene 187: 8392.
  • Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE. 2007. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target B CL2. Nat Cell Biol 9: 470478.
  • Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A, Yoshimatsu K, Konno S, Aiba M, Ogawa K. 2004. Expression of twist and wnt in human breast cancer. Anticancer Res 24: 38513856.
  • Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS, Jr. 2001. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol Cell Biol 21: 84288436.
  • Wu R, Zhang L, Hoagland MS, Swanson HI. 2007. Lack of the aryl hydrocarbon receptor leads to impaired activation of AKT/protein kinase B and enhanced sensitivity to apoptosis induced via the intrinsic pathway. J Pharmacol Exp Ther 320: 448457.
  • Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927939.
  • Yoshizaki T, Sato H, Furukawa M. 2002. Recent advances in the regulation of matrix metalloproteinase 2 activation: From basic research to clinical implication (Review). Oncol Rep 9: 607611.
  • Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931940.